Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
The report details the trend, potential and market size of Ponatinib Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ponatinib Drugsmarket, defines the market attractiveness level of Ponatinib Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ponatinib Drugs industry, describes the types of Ponatinib Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ponatinib Drugs market and the development prospects and opportunities of Ponatinib Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ponatinib Drugs market in Chapter 13.
By Player:
ARIAD Pharmaceuticals
By Type:
45mg
15mg
By End-User:
CML
ALL
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ponatinib Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ponatinib Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ponatinib Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ponatinib Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ponatinib Drugs Market Analysis and Outlook to 2022
-
7.1 Global Ponatinib Drugs Consumption (2017-2022)
-
7.2 United States Ponatinib Drugs Consumption (2017-2022)
-
7.3 Europe Ponatinib Drugs Consumption (2017-2022)
-
7.4 China Ponatinib Drugs Consumption (2017-2022)
-
7.5 Japan Ponatinib Drugs Consumption (2017-2022)
-
7.6 India Ponatinib Drugs Consumption (2017-2022)
-
7.7 South Korea Ponatinib Drugs Consumption (2017-2022)
8 Region and Country-wise Ponatinib Drugs Market Analysis and Outlook to 2028
-
8.1 Global Ponatinib Drugs Consumption Forecast (2022-2028)
-
8.2 United States Ponatinib Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Ponatinib Drugs Consumption Forecast (2022-2028)
-
8.4 China Ponatinib Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Ponatinib Drugs Consumption Forecast (2022-2028)
-
8.6 India Ponatinib Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Ponatinib Drugs Consumption Forecast (2022-2028)
9 Global Ponatinib Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Ponatinib Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 45mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 15mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Ponatinib Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global CML Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ALL Consumption and Growth Rate (2017-2022)
10 Global Ponatinib Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Ponatinib Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 45mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 15mg Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ponatinib Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global CML Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global ALL Consumption Forecast and Growth Rate (2022-2028)
11 Global Ponatinib Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ponatinib Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ponatinib Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ponatinib Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ponatinib Drugs Market Competitive Analysis
-
14.1 ARIAD Pharmaceuticals
-
14.1.1 ARIAD Pharmaceuticals Company Details
-
14.1.2 ARIAD Pharmaceuticals Ponatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ponatinib Drugs
-
Figure Ponatinib Drugs Picture
-
Table Global Ponatinib Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ponatinib Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ponatinib Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ponatinib Drugs Consumption by Country (2017-2022)
-
Figure United States Ponatinib Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Ponatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Ponatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Ponatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Ponatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ponatinib Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Ponatinib Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Ponatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ponatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ponatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ponatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ponatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ponatinib Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 45mg Consumption and Growth Rate (2017-2022)
-
Figure Global 15mg Consumption and Growth Rate (2017-2022)
-
Figure Global CML Consumption and Growth Rate (2017-2022)
-
Figure Global ALL Consumption and Growth Rate (2017-2022)
-
Figure Global 45mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 15mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CML Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALL Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ponatinib Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ponatinib Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table ARIAD Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table ARIAD Pharmaceuticals Ponatinib Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ARIAD Pharmaceuticals Ponatinib Drugs Product and Service
-
